Aktiia closes its USD 17.5m series A financing round. The advisors

Aktiia, the hypertension health-tech firm, has successfully closed its USD 17.5 million Series A funding led by Molten Ventures (formerly Draper Esprit) based in the UK, with participation from 415 Capital, Redalpine, Verve Ventures Partners and Translink Capital.  

The new capital will be used to expand Aktiia’s commercial footprint in the NHS and key healthcare markets across Europe and to build out a team focusing on the healthcare channel. A percentage of the Series A funds will also go towards obtaining FDA clearance to enable expansion to the US market. 

Id est avocats has advised Aktiia in this financing round.

Wenger Vieli advised Molten Ventures on all legal aspects in Switzerland. Our team was led by Beat Speck (partner, m&a, pictured) and comprised Michael Baier (senior associate, venture capital / m&a), Michèle Joho-Menotti (associate, m&a) and Claudia Keller (counsel, ip / ict). 

 

 

 

 

 

FabioAdmin

SHARE